Yann Ayotte
500 Boulevard Cartier Ouest
Laval, QC H7V5B7, Canada
Laval, QC H7V5B7, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Repurposing Drugs and Synergistic Combinations as Potential Therapies for Inhibiting SARS-CoV-2 and Coronavirus Replication.
Journal: ACS pharmacology & translational science
Published: August 23, 2024
Evaluation of expanded 2-aminobenzothiazole library as inhibitors of a model histidine kinase and virulence suppressors in Pseudomonas aeruginosa.
Journal: Bioorganic chemistry
Published: January 25, 2024
Robust Strategy for Hit-to-Lead Discovery: NMR for SAR.
Journal: Journal of medicinal chemistry
Published: September 21, 2023
Evaluation of Expanded 2-Aminobenzothiazole Library for Inhibition of Pseudomonas aeruginosa Virulence Phenotypes.
Journal: bioRxiv : the preprint server for biology
Published: May 19, 2023
N-Phenylpyridine-3-Carboxamide and 6-Acetyl-1H-Indazole Inhibit the RNA Replication Step of the Dengue Virus Life Cycle.
Journal: Antimicrobial agents and chemotherapy
Published: January 26, 2023
Fragment-Based Phenotypic Lead Discovery To Identify New Drug Seeds That Target Infectious Diseases.
Fragment-Based Phenotypic Lead Discovery To Identify New Drug Seeds That Target Infectious Diseases.
Journal: ACS chemical biology
Published: October 26, 2021
Exposing Small-Molecule Nanoentities by a Nuclear Magnetic Resonance Relaxation Assay.
Journal: Journal of medicinal chemistry
Published: August 20, 2019
Fragment-Based Phenotypic Lead Discovery: Cell-Based Assay to Target Leishmaniasis.
Journal: ChemMedChem
Published: March 13, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026